Results 101 to 110 of about 1,285 (168)

Immunotherapy and impact on tissue reservoirs. [PDF]

Curr Opin HIV AIDS
King HAD, Angelovich TA, Moso MA, Pascoe RD, Churchill MJ, Lewin SR.   +5 more
europepmc   +1 more source

Molecular and Phylogenetic Characterization of <i>Onchocerca flexuosa</i> in Red Deer from South-Eastern Europe. [PDF]

Pathogens
Martinuš E, Gagović E, Hodžić A, Jurković Žilić D, Beck R.   +4 more
europepmc   +1 more source

How Linked Interdisciplinary CUREs Impact Student Social Networks and Thinking About the Value of Other Disciplines. [PDF]

CBE Life Sci Educ
Freeland F, Boyd EA, Walker JP, Vance-Chalcraft HD.   +3 more
europepmc   +1 more source

Krim-Kongo-Virus [PDF]

, 2009
openaire   +1 more source

Assessing the consistency of flammability indices across field and laboratory experimental tests for some Moroccan forest fuels. [PDF]

PLoS One
Essaghi S, Hachmi M, Laajali S, Chikhaoui M, Hamouda A.   +4 more
europepmc   +1 more source

Real-life effectiveness 1 year after switching to avalglucosidase alfa in late-onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort study. [PDF]

Eur J Neurol
Tard C, Bouhour F, Michaud M, Beltran S, Fournier M, Demurger F, Lagrange E, Nollet S, Sacconi S, Noury JB, Magot A, Cintas P, Renard D, Deibener-Kaminsky J, Lefeuvre C, Davion JB, Salort-Campana E, Arrassi A, Taouagh N, Spinazzi M, Pompe Study Group, Attarian S, Laforêt P.   +22 more
europepmc   +1 more source

Heterozygous and generalist MxA super-restrictors overcome breadth-specificity trade-offs in antiviral restriction. [PDF]

Sci Adv
Geiger RA, Khera D, Tenthorey JL, Kochs G, Graf L, Emerman M, Malik HS.   +6 more
europepmc   +1 more source

Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis. [PDF]

NPJ Parkinsons Dis
Lanore A, Tesson C, Basset A, Lejeune FX, Cogan G, Mangone G, Sambin S, Bertille N, Anheim M, Arnulf I, Ansquer S, Brandel JP, Brefel-Courbon C, Defebvre L, Drapier S, Eusebsio A, Fabbri M, Giordana C, Hainque E, Lehericy S, Marques A, Moreau C, Moro E, Ory F, Rolland AS, Thobois S, Vidailhet M, Devos D, Mariani LL, Lesage S, Brice A, Corvol JC, Predistim study group, Iceberg study group, NSPark study group.   +34 more
europepmc   +1 more source

Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial.

JAMA Cardiol
Krim SR, Anand S, Greene SJ, Chen A, Wojdyla D, Vilaro J, Haught H, Herre JM, Eisenstein EL, Anstrom KJ, Pitt B, Velazquez EJ, Mentz RJ.   +12 more
europepmc   +1 more source